212 related articles for article (PubMed ID: 28928842)
1. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
[TBL] [Abstract][Full Text] [Related]
2. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of Hepatic Arterial Infusion Chemotherapy with 5-Fluorouracil/Cisplatin and Systemic Chemotherapy with Ramucirumab in Alpha-Fetoprotein-Producing Gastric Cancer with Multiple Liver Metastases.
Doi Y; Takii Y; Mitsugi K; Kimura K; Mihara Y
Case Rep Oncol Med; 2018; 2018():5402313. PubMed ID: 30534453
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.
Weng W; Zhang M; Ni S; Tan C; Xu M; Wang X; Sun H; Wang L; Huang D; Sheng W
J Gastrointest Oncol; 2022 Jun; 13(3):1035-1045. PubMed ID: 35837176
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
[TBL] [Abstract][Full Text] [Related]
8. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
Zuo CT; Ju Q
Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
[TBL] [Abstract][Full Text] [Related]
9. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
Li XD; Wu CP; Ji M; Wu J; Lu B; Shi HB; Jiang JT
World J Surg Oncol; 2013 Oct; 11():246. PubMed ID: 24083471
[TBL] [Abstract][Full Text] [Related]
10. Complete response and long‑term survival after stereotactic body radiotherapy in a patient with liver metastasis from α‑fetoprotein‑producing gastric cancer: A case report.
Kanda T; Matsumoto Y; Nihei K; Takeishi T; Naito M
Oncol Lett; 2024 Feb; 27(2):61. PubMed ID: 38192667
[TBL] [Abstract][Full Text] [Related]
11.
Maruyama S; Furuya S; Shiraishi K; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
World J Gastrointest Oncol; 2018 Oct; 10(10):344-350. PubMed ID: 30364858
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract][Full Text] [Related]
13. Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases.
Fang YU; Wang L; Yang N; Gong X; Zhang YU; Qin S
Oncol Lett; 2015 Nov; 10(5):3021-3025. PubMed ID: 26722283
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study.
Zhang X; Wang W; Tian B; Wang Y; Jing J
Clin Med Insights Oncol; 2022; 16():11795549221120158. PubMed ID: 36104997
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature.
Ota T; Sakashita K; Sawada R; Seki K; Maeda H; Tanaka N; Tsujinaka T
Surg Case Rep; 2023 May; 9(1):71. PubMed ID: 37150760
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of ramucirumab in advanced gastric cancer.
Chan MM; Sjoquist KM; Zalcberg JR
Biologics; 2015; 9():93-105. PubMed ID: 26451083
[TBL] [Abstract][Full Text] [Related]
17. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.
Li W; Li Q; Yu Y; Wang Y; Chen E; Chen L; Wang Z; Cui Y; Liu T
Cancer Manag Res; 2020; 12():11113-11119. PubMed ID: 33173344
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
[TBL] [Abstract][Full Text] [Related]
19. A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Carcinoma and Disseminated Intravascular Coagulation.
Longo R; Carassou P; Leguay C; Basin S; Thiebaut V; Paraschiv EA; Enea AM
Am J Case Rep; 2021 Mar; 22():e928369. PubMed ID: 33667215
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Kamei S; Kono K; Amemiya H; Takahashi A; Sugai H; Ichihara F; Fujii H; Matsumoto Y
J Gastroenterol; 2003; 38(6):540-7. PubMed ID: 12825129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
